These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 23451207)
1. Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8). Tiwari N; Meyer-Schaller N; Arnold P; Antoniadis H; Pachkov M; van Nimwegen E; Christofori G PLoS One; 2013; 8(2):e57329. PubMed ID: 23451207 [TBL] [Abstract][Full Text] [Related]
2. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition. Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276 [TBL] [Abstract][Full Text] [Related]
3. KLF4 Plays an Essential Role in Corneal Epithelial Homeostasis by Promoting Epithelial Cell Fate and Suppressing Epithelial-Mesenchymal Transition. Tiwari A; Loughner CL; Swamynathan S; Swamynathan SK Invest Ophthalmol Vis Sci; 2017 May; 58(5):2785-2795. PubMed ID: 28549095 [TBL] [Abstract][Full Text] [Related]
4. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression. Zhu Z; Yu Z; Wang J; Zhou L; Zhang J; Yao B; Dou J; Qiu Z; Huang C Cell Physiol Biochem; 2018; 46(1):238-252. PubMed ID: 29587259 [TBL] [Abstract][Full Text] [Related]
5. Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. Yori JL; Johnson E; Zhou G; Jain MK; Keri RA J Biol Chem; 2010 May; 285(22):16854-63. PubMed ID: 20356845 [TBL] [Abstract][Full Text] [Related]
6. Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Yori JL; Seachrist DD; Johnson E; Lozada KL; Abdul-Karim FW; Chodosh LA; Schiemann WP; Keri RA Neoplasia; 2011 Jul; 13(7):601-10. PubMed ID: 21750654 [TBL] [Abstract][Full Text] [Related]
7. Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression. Lin ZS; Chu HC; Yen YC; Lewis BC; Chen YW PLoS One; 2012; 7(8):e43593. PubMed ID: 22937066 [TBL] [Abstract][Full Text] [Related]
8. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer. Lee HK; Lee DS; Park JC BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941 [TBL] [Abstract][Full Text] [Related]
9. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition. Liu YN; Abou-Kheir W; Yin JJ; Fang L; Hynes P; Casey O; Hu D; Wan Y; Seng V; Sheppard-Tillman H; Martin P; Kelly K Mol Cell Biol; 2012 Mar; 32(5):941-53. PubMed ID: 22203039 [TBL] [Abstract][Full Text] [Related]
10. Doxycycline inducible Krüppel-like factor 4 lentiviral vector mediates mesenchymal to epithelial transition in ovarian cancer cells. Chen Z; Wang Y; Liu W; Zhao G; Lee S; Balogh A; Zou Y; Guo Y; Zhang Z; Gu W; Li C; Tigyi G; Yue J PLoS One; 2014; 9(8):e105331. PubMed ID: 25137052 [TBL] [Abstract][Full Text] [Related]
11. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration. Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803 [TBL] [Abstract][Full Text] [Related]
12. Regulation of EMT by KLF4 in gastrointestinal cancer. Cui J; Shi M; Quan M; Xie K Curr Cancer Drug Targets; 2013 Nov; 13(9):986-95. PubMed ID: 24168184 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic repression of Krüppel-like factor 4 through Dnmt1 contributes to EMT in renal fibrosis. Xiao X; Tang W; Yuan Q; Peng L; Yu P Int J Mol Med; 2015 Jun; 35(6):1596-602. PubMed ID: 25892014 [TBL] [Abstract][Full Text] [Related]
14. Loss of the Krüppel-like factor 4 tumor suppressor is associated with epithelial-mesenchymal transition in colorectal cancer. Agbo KC; Huang JZ; Ghaleb AM; Williams JL; Shroyer KR; Bialkowska AB; Yang VW J Cancer Metastasis Treat; 2019; 5():. PubMed ID: 32566755 [TBL] [Abstract][Full Text] [Related]
15. Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition. Diepenbruck M; Waldmeier L; Ivanek R; Berninger P; Arnold P; van Nimwegen E; Christofori G J Cell Sci; 2014 Apr; 127(Pt 7):1523-36. PubMed ID: 24554433 [TBL] [Abstract][Full Text] [Related]
16. Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway. Das S; Becker BN; Hoffmann FM; Mertz JE BMC Cell Biol; 2009 Dec; 10():94. PubMed ID: 20025777 [TBL] [Abstract][Full Text] [Related]
17. SIRT1 deacetylates KLF4 to activate Claudin-5 transcription in ovarian cancer cells. Zhang X; Chen J; Sun L; Xu Y J Cell Biochem; 2018 Feb; 119(2):2418-2426. PubMed ID: 28888043 [TBL] [Abstract][Full Text] [Related]
18. miR-21 and KLF4 jointly augment epithelial‑mesenchymal transition via the Akt/ERK1/2 pathway. Liu CH; Huang Q; Jin ZY; Zhu CL; Liu Z; Wang C Int J Oncol; 2017 Apr; 50(4):1109-1115. PubMed ID: 28197636 [TBL] [Abstract][Full Text] [Related]
19. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243 [TBL] [Abstract][Full Text] [Related]
20. Esophageal squamous cell dysplasia and delayed differentiation with deletion of krüppel-like factor 4 in murine esophagus. Tetreault MP; Yang Y; Travis J; Yu QC; Klein-Szanto A; Tobias JW; Katz JP Gastroenterology; 2010 Jul; 139(1):171-81.e9. PubMed ID: 20347813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]